YILDIRIM, H. Ç. Et Al. 2022. Differences between Hyperprogressive Disease and Progressive Disease in Patients Receiving Immunotherapy. EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , vol.6, no.1 , 59-63.

YILDIRIM, H. Ç., GÜVEN, D. C., AKTEPE, O. H., TABAN, H., Yilmaz, F., Yasar, S., ... AKTAŞ, B. Y.(2022). Differences between Hyperprogressive Disease and Progressive Disease in Patients Receiving Immunotherapy. EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , vol.6, no.1, 59-63.

YILDIRIM, HASAN Et Al. "Differences between Hyperprogressive Disease and Progressive Disease in Patients Receiving Immunotherapy," EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , vol.6, no.1, 59-63, 2022

YILDIRIM, HASAN Ç. Et Al. "Differences between Hyperprogressive Disease and Progressive Disease in Patients Receiving Immunotherapy." EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , vol.6, no.1, pp.59-63, 2022

YILDIRIM, H. Ç. Et Al. (2022) . "Differences between Hyperprogressive Disease and Progressive Disease in Patients Receiving Immunotherapy." EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , vol.6, no.1, pp.59-63.

@article{article, author={HASAN ÇAĞRI YILDIRIM Et Al. }, title={Differences between Hyperprogressive Disease and Progressive Disease in Patients Receiving Immunotherapy}, journal={EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY}, year=2022, pages={59-63} }